Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IL-18 binding molecules

IL-18 binding molecules

US Patent 11111293 · Granted Sep 7, 2021

Estimated economic value: $17,490,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Antibodies targeting ActRIIA and ActRIIB2025
Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory dis2024
Variant CD58 domains and uses thereof2024
Method of manufacturing bispecific antibodies, bispecific antibodies and therape2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 bin2024
Method of treating cancer by administering immune effector cells expressing a ch2024
Immune-stimulating humanized monoclonal antibodies against human interleukin-2, 2023
Antibodies to PMEL17 and conjugates thereof2023
Chemokine receptor binding polypeptides2022
RNAi inhibition of alpha-ENaC expression2021
Method of detecting TIM-3 using antibody molecules to TIM-32021